Company Filing History:
Years Active: 2016
Title: Holger Bernhardt: Innovator in Live Vector Vaccines
Introduction
Holger Bernhardt is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of vaccine development, particularly in the area of live vector vaccines. His work focuses on creating vaccines that are highly attenuated and contain minimal or no animal-derived components.
Latest Patents
Holger holds a patent for the invention titled "Depletion of host cell components from live vector vaccines." This patent addresses the challenges associated with producing live vaccines that are both effective and safe. The invention outlines methods for the production and purification of live enveloped viruses suitable for vaccination, emphasizing the use of specifically designed cell lines as producer substrates.
Career Highlights
Holger Bernhardt is associated with Probiogen AG, a company that specializes in biopharmaceuticals and vaccine development. His expertise in the field has led to advancements in the production of live vaccines, contributing to the overall improvement of vaccine safety and efficacy.
Collaborations
Holger has collaborated with notable colleagues, including Ingo Jordan and Stefan Hartmann. Their combined efforts in research and development have furthered the understanding and innovation in vaccine technology.
Conclusion
Holger Bernhardt's work in the field of live vector vaccines exemplifies the importance of innovation in healthcare. His contributions are paving the way for safer and more effective vaccines, ultimately benefiting public health.